Journals / Koşuyolu Heart Journal / 2009 / Cilt: 12 - Sayı: 1

Non-Cardiac Surgery After Percutaneous Coronary Interventions

Perkütan Koroner Giriflim Sonras› Kalp D›fl› Cerrahi

Pages
39–45
Publication Date
2008-01-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We tried to review the timing for non-cardiac surgeries, surgical techniques and stent-related problems in these patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In accordance with the trend of the world, the treatment with coronary intervention has become widespread in our country.
📊
Key Findings & Data:With improvement in life standards, the average life expectancy has also increased.
💡
Conclusion & Impact:We tried to review the timing for non-cardiac surgeries, surgical techniques and stent-related problems in these patients.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Perkütan koroner giriflim · stentleme · klopidogrel

Abstract

In accordance with the trend of the world, the treatment with coronary intervention has become widespread in our country. With improvement in life standards, the average life expectancy has also increased. Non-cardiac surgery was performed in approximately 5 % of the patients who underwent percutaneous coronary interventions. The timing of non-cardiac surgery is well-defined in cases of bare metal stents which are most widely used in percutaneous coronary interventions. Unfortunately, we still do not know the optimal timing for surgery in cases of drug-eluting stents which are increasingly preferred for lesser restenosis. The stent-implanted patients have always been challenges for various surgeons. We tried to review the timing for non-cardiac surgeries, surgical techniques and stent-related problems in these patients.

Özet

Perkütan koroner girflimler ile tedavi dünyada oldu¤u gibi ülkemizde de yayg›nlaflm›flt›r. Toplulumuzun yaflam flartlar›n›n iyileflmesi ile yafl ortalamas› yükselmifltir. Perkütan koroner tedavi yap›lan hastalar›n yaklafl›k olarak yüzde befline kalp d›fl› cerrahi gerekmektedir. Perkütan koroner tedavide yayg›n olarak kulland›¤›m›z bare metal stentlerde kalp d›fl› cerrahi zaman› netleflmifltir. Restenoz oran› ilaç sal›n›ml› stentler ile önemli oranda çözülmüflken bu hastalarda optimal kalp d›fl› cerrahi zaman› belli de¤ildir. Koroner arter problemlerini stentler ile çözüme ulaflt›r›lan hastalar kardiyovasküler cerrahlar d›fl›ndaki cerrahlar taraf›ndan her zaman önemli problem olarak görülmektedirler. Bu hastalarda kalp d›fl› cerrahi zamanlar›,cerrahi teknikleri ve stentler ile ilgili problemleri gözden geçirdik.

🔖

Cite This Article

EMİRO¤LU, Y., PALA, S., BOZTOSUN, B. (2008). Non-Cardiac Surgery After Percutaneous Coronary Interventions. Koşuyolu Heart Journal, Cilt: 12 - Sayı: 1, 39–45. https://ajindex.com/articles/64150

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics 2006 update: A report from the American Heart Association Statistics Commit- tee and Stroke Statistics Subcommittee. Circulation 2006; 113:e85–e151. Serruys PW, Kutryk MJB, Ong ATL. Coronary-artery stents. N Engl J. Med 2006; 354:483–495.
  2. Tu JV, Bowen J, Chiu M, Ko DT, Austin PC, He Y, Hopkins R, Tarride JE, Blackhouse G, Lazzam C, Cohen EA, Goeree R: Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 2007; 357:1393–402 McLean TR: In New York State, do more percutaneo- us coronary interventions mean fewer or more complex referrals to cardiac surgeons? Am Heart Hosp J 2008;:588–95
  3. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidog- rel in addition to aspirin in patients with acute coronary syndromes without ST-segment in elevation. N Engl J Med 2001; 345:494–502.
  4. Mehta SR, Yusuf S, Peters RJG, et al. Effects of pret- reatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percuta- neous coronary intervention: the PCI-CURE study. Lancet2001; 358:527–533. ACC/AHA Ua -Nstemı Guıdeline Revision,Circulation, August 14 p.184) Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A: Incidence, predictors, and outco- me of thrombosis after successful implantation of drug- eluting stents. JAMA 2005; 293:2126–30
  5. Pfisterer M, Brunner-La Rocca HP, Buser PT, Ricken- bacher P, Hunziker P, Mueller C, Jeger R, Bader F, Oss- wald S, Kaiser C: Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48:2584–91
  6. Ferrari E, Benhamou M, Cerboni P, et al. Coronary syndromes following aspirin withdrawal. A special risk for late stent thrombosis. J Am Coll Cardiol 2005; 45:456–459.
  7. Pfisterer M, Brunner La-Rocca HP,Buser PT, etal. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. J Am Coll Cardiol 2006; 48:2584–2591.
  8. Spertus JA, Kettelkampf R, Vance C, et al. Prevalen- ce, predictors, and outcomes of premature discontinu- ation of thienopyridine therapy after drug-eluting stent placement (Results form the PREMIER Registry). Circu- lation 2006; 113:2803–2809.
  9. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Mont